ENDPOINTS

Post-Hoc: China tensions both help and hurt Illumina

In the souring US-China relationship, there are winners and losers. DNA sequencing giant Illumina is both. Illumina got bad news this week when China blacklisted it, which could end in restrictions or ...

Feb 9, 2025 - 21:49
 0
Post-Hoc: China tensions both help and hurt Illumina
In the souring US-China relationship, there are winners and losers. DNA sequencing giant Illumina is both. Illumina got bad news this week when China blacklisted it, which could end in restrictions or ...
Read More

Tags:

Previous Article

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Next Article

Sanofi, AstraZeneca back Teva's call to rehear case on patent listings

Related Posts

Longtime Sandoz exec announces retirement; Lilly appoints head of India

Longtime Sandoz exec announces retirement; Lilly appoin...

Feb 9, 2025  0

Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

Decade after $8B deal, Roche offloads InterMune to myst...

Feb 10, 2025  0

Updated: Hospital group blasts proposed 340B rebate models, requests to join lawsuits with HHS

Updated: Hospital group blasts proposed 340B rebate mod...

Feb 9, 2025  0